Capecitabine and Oxaliplatin (XELOX) for the Treatment of Patients with Metastatic Gastric Cancer and Severe Liver Dysfunction
Seung Jae Hwang, Jong Won Park, Sehe Dong Lee, Gyong Jung Kim, Cheol Ho Sin, Seung-Hyun Nam, Bong-Seog Kim
Korean J Intern Med. 2006;21(4):252-255. Published online 2006 Dec 31 DOI: https://doi.org/10.3904/kjim.2006.21.4.252
Citations to this article as recorded by 
Identification of the key target profiles underlying the drugs of narrow therapeutic index for treating cancer and cardiovascular disease
Jiayi Yin, Xiaoxu Li, Fengcheng Li, Yinjing Lu, Su Zeng, Feng Zhu
Computational and Structural Biotechnology Journal.2021; 19: 2318. CrossRef
Treatment options for metastatic colorectal cancer in patients with liver dysfunction due to malignancy
L. Faugeras, A. Dili, A. Druez, B. Krug, C. Decoster, L. D’Hondt
Critical Reviews in Oncology/Hematology.2017; 115: 59. CrossRef
Treatment approach in patients with hyperbilirubinemia secondary to liver metastases in gastrointestinal malignancies: a case series and review of literature
Julia Quidde, Marc Azémar, Carsten Bokemeyer, Dirk Arnold, Alexander Stein
Therapeutic Advances in Medical Oncology.2016; 8(3): 144. CrossRef
Safe Use of FOLFOX in Two Patients With Metastatic Colorectal Carcinoma and Severe Hepatic Dysfunction
Christoph Roderburg, Nicole do O, Roland Fuchs, Jhenee Bubenzer, Michael Spannbauer, Tom Luedde, Christian Trautwein, Jens J.W. Tischendorf
Clinical Colorectal Cancer.2011; 10(1): E6. CrossRef